F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 41 filers reported holding F-STAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $255,000 | -82.2% | 49,708 | -78.2% | 0.00% | – |
| Q2 2022 | $1,431,000 | +37.5% | 228,495 | -22.0% | 0.00% | – |
| Q1 2022 | $1,041,000 | -31.6% | 292,993 | -3.3% | 0.00% | – |
| Q4 2021 | $1,522,000 | -31.0% | 303,100 | +0.6% | 0.00% | – |
| Q3 2021 | $2,205,000 | -42.0% | 301,145 | -32.0% | 0.00% | -100.0% |
| Q2 2021 | $3,804,000 | +380300.0% | 442,780 | +1159.4% | 0.00% | – |
| Q1 2021 | $1,000 | – | 35,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |